glp-1 and liver Why are agonists being used to treat patients with nonalcoholic fatty disease? GLP-1 therapy's potential in treating

Schedule a free consultation to discuss your case.

Lillys new safety allegations add fuel to lawsuits and FDA actions targeting telehealth sellers of compounded weight loss drugs.

GLP-1 receptor agonists can trigger heartburn and reflux in some patients by slowing stomach emptying and increasing intragastric pressure

Tirzepatide, a dual GLP-1 and GIP receptor agonist, has...

This plan is ideal for busy adults and families who are tracking protein while using GLP-1 medications

Our blog series on GLP-1 agonists for weight loss is aimed at unpacking the science behind this new frontier in weight management, presenting a detailed overview of how they work, their efficacy, and their role in a holistic approach to health and wellness.